MONTREAL--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, showcased its advanced cellular science research and drug discovery products at the 2007 Society for Biomolecular Science (SBS) 13th Annual Meeting, April 15-19, in Montreal, Canada. The newly enhanced technology offerings focus on powerful cell-based screening and high content analysis platforms. A cell-based approach to screening offers researchers greater insight into the complex mechanisms of the cell, providing higher-value content and more clinically relevant data for drug discovery.
